On September 10, 2026, Dr. Duane Nash resigned as a member of the Board of Directors of Immunic, Inc. The resignation was not due to any disagreement with the company regarding its operations, policies, or practices. Consequently, the Board size was reduced from ten members to nine members. Immunic, Inc. operates in the biotechnology industry and develops immunotherapies for autoimmune diseases.
